Global Migraine Therapeutics Market 2018-2022| Key Insights and Forecasts| Technavio

Technavio has published a new market research report on the global migraine therapeutics market from 2018-2022. (Graphic: Business Wire)

LONDON--()--The global migraine therapeutics market is expected to post a CAGR of more than 5% over the period 2018-2022, according to the latest market research report by Technavio.

A key factor driving the growth of the market is the increase in the number of patients suffering from migraine. Migraine is a neurological disease which is highly prevalent across the world. The frequent use of some medications can lead to migraine. Women are believed to be more susceptible to migraine and less responsive to migraine treatment. The high prevalence of this ailment is expected to increase the demand for migraine therapeutics.

This market research report on the global migraine therapeutics market 2018-2022 further provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Technavio classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

In this report, Technavio highlights the growth in the number of migraine treatment awareness programs as one of the key emerging trends in the global migraine therapeutics market:

Global migraine therapeutics market: Growth in the number of migraine treatment awareness programs

Migraine is a common and highly disabling neurological disorder. Various migraine treatment awareness programs are being conducted by several organizations for educating and helping patients suffering from migraine. Some such organizations include The Migraine Trust, U.S. Pain Foundation, the American Migraine Foundation etc. These organizations observe the week starting from the first Sunday in September as the migraine awareness week to raise awareness of the condition and to highlight the impact of migraine among people. Such campaigns seek to get funding for migraine treatment in the US in addition to increasing awareness about the ailment.

“Many research activities have been conducted for the development of a specific and effective preventative treatment for migraine. There is high availability of several late-stage pipeline products which are expected to be launched in the coming years. Such development augurs well for the growth of the market during the forecast period,” says a senior analyst at Technavio for research on infectious and rare diseases.

Global migraine therapeutics market: Segmentation analysis

This market research report segments the global migraine therapeutics market by product (drugs and devices), by treatment (preventative treatment and migraine abortive treatment) and key regions (the Americas, APAC, and EMEA).

Americas held the highest share of the global migraine therapeutics market in 2017, accounting for a market share of around 59%, followed by EMEA and APAC respectively. The market share of the Americas is expected to witness the maximum increase during the forecast period, while APAC is expected to see a decline in its market share over the forecast period.

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market sizing
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Release Summary

The global migraine therapeutics market is expected to post a CAGR of over 5% from 2018-2022, according to the latest research report by Technavio.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200